Violation Tracker Summary for Primary Offense Type

Offense Type: 
off-label or unapproved promotion of medical products
Penalty Total since 2000: 
$20,135,257,853
Number of Penalty Records: 
118
Note: 
The totals here are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.

Top 10 Parent CompaniesTotal Penalty $Number of Records
Pfizer$3,373,675,00010
Johnson & Johnson$3,136,000,00010
GlaxoSmithKline$3,004,361,8604
AbbVie$2,514,000,0007
Eli Lilly$1,608,100,0009
Merck$1,422,000,0007
Amgen$833,000,0003
Merck KGaA (EMD)$704,000,0002
AstraZeneca$594,000,0004
Bristol-Myers Squibb$534,500,0003


Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
Download results as CSV or XML
Company Parent Parent Major Industry Year Agency Penalty Amountsort icon
Medicis Pharmaceutical Corporation Bausch Health pharmaceuticals 2007 MULTI-AG (*) $4,000,000
Atricure Inc. AtriCure medical equipment and supplies 2010 FDA $3,760,000
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2010 KY-AG $3,700,000
Novo Nordisk Inc. Novo Holdings A/S pharmaceuticals 2011 MULTI-AG (*) $3,574,209
Carefusion Corporation Becton Dickinson medical equipment and supplies 2019 USAO $3,300,000
Cypress Pharmaceutical Inc. Currax Pharmaceuticals pharmaceuticals 2012 FDA $2,800,000
Otsuka American Pharmaceutical Inc. Otsuka Pharmaceutical pharmaceuticals 2008 MULTI-AG (*) $1,700,000
Endoscopic Technologies Inc.   2009 DOJ_CIVIL $1,400,000
Insys Insys Therapeutics pharmaceuticals 2015 OR-AG $1,100,000
Novo Nordisk Inc. Novo Holdings A/S pharmaceuticals 2017 CA-INS $1,100,000
GlaxoSmithKline GlaxoSmithKline pharmaceuticals 2009 KY-AG $661,860
Globus Medical Inc. Globus Medical medical equipment and supplies 2012 FDA $550,000
Insys Therapeutics, Inc. Insys Therapeutics pharmaceuticals 2017 MA-AG $500,000
ISTA Pharmaceuticals, Inc. Bausch Health pharmaceuticals 2013 MULTI-AG (*) $390,253
Pfizer Inc. Pfizer pharmaceuticals 2013 MA-AG $375,000
Mylan Specialty, L.P. Mylan pharmaceuticals 2013 MA-AG $250,000
Stryker Biotech, LLC Stryker medical equipment and supplies 2011 OR-AG $167,000
Stryker Biotech Stryker medical equipment and supplies 2010 MA-AG $135,000
Download results as CSV or XML
(*): Some penalties are partial or complete duplicates of other penalty records, either because a DOJ settlement duplicates an agency record or because EPA listed the full penalty for a company for each of the company's relevant facilities. Penalty amounts marked with an asterisk have been identified by Good Jobs First as duplicating other penalty amounts.